RPRX
Royalty PharmaPlc
Royalty PharmaPlc 13F Holders
RPRX Stock Ownership Activity
- # of activities:
- 2
- AVG reported price*:
- $30.74
- Current price*:
- +90.60%($58.59)
2 value investing gurus have made changes to the Royalty PharmaPlc (RPRX) position according to the gurus' 2023 Q2 SEC quarterly report(s). RPRX has been bought (as a new position) by 1 guru(s), the number of RPRX shares has been decreased by 1 super investor(s).
Which gurus or hedge funds bought RPRX in 2023 Q2?
According to the 2023 Q2 SEC filing(s) Royalty PharmaPlc (RPRX) has been bought by Torray Fund (new buy).
To see more about who is investing in Royalty PharmaPlc (RPRX), please go to the RPRX ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.